住院成人血钠波动及临界低钠/高钠与死亡风险增加相关
该回顾性队列研究纳入Mayo Clinic 2011–2013年住院成人60944例,评估血钠波动与院内及1年全因死亡率的关系。血钠波动≥6 mEq/L见于40.6%患者,校正混杂因素后与院内和1年死亡率显著相关,且呈剂量依赖;参考范围内波动或临界低钠/高钠亦与死亡率增加相关。
要点
- 住院期间血钠波动≥6 mEq/L与院内及1年死亡率独立相关,呈剂量依赖。
- 即使血钠在参考范围内波动或仅临界低钠/高钠,死亡风险也增加。
- 入院时血钠正常者住院期间仍可能发生低钠或高钠,需动态监测。
核心结论
- 住院成人血钠波动≥6 mEq/L是不依赖入院血钠的独立预测因子,与短期和长期死亡率逐步增加相关。
- 临界低钠(133–137 mEq/L)或高钠(143–147 mEq/L)及参考范围内波动亦与院内和1年死亡率增加相关。
研究设计与样本
- 回顾性队列研究,筛查Mayo Clinic Rochester 2011年1月至2013年12月所有成年住院患者(n=147358),最终分析唯一患者60944例,平均年龄63±17岁。
- 主要暴露为血清钠浓度波动,结局为院内和1年全因死亡率。
主要发现
- 入院时低钠者占17%(n=10066),高钠者占1.4%(n=852)。
- 住院期间新发低钠11044例、高钠4128例,分别占全部低钠和高钠患者的52.3%和82.9%。
- 校正混杂因素后,院内和1年死亡率的调整比值比随血钠波动增大呈剂量依赖增加,从1.47至5.48(所有95%CI>1.0)。
关键数值与推荐
- 血钠波动≥6 mEq/L与院内和1年死亡率显著相关(调整后OR 1.47–5.48,所有95%CI>1.0)。
- 与血钠138–142 mEq/L相比,参考范围内波动(135–145 mEq/L)或临界低钠(133–137 mEq/L)、临界高钠(143–147 mEq/L)均与院内和1年死亡率增加相关。
临床怎么用
- 住院期间应动态监测血钠,关注波动幅度而非仅看单次值。
- 对血钠波动≥6 mEq/L或处于临界低钠/高钠范围的患者,应评估死亡风险并加强管理。
局限性
- 回顾性单中心研究,可能存在残余混杂。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to evaluate short-term and long-term mortalities in a cohort of unselected hospitalized patients with serum sodium concentration ([Na+]) variations within and outside of reference range. METHODS: All adult patients admitted to the Mayo Clinic, Rochester, MN, USA from January 2011 to December 2013 (n = 147358) were retrospectively screened. Unique patients admitted during the study period were examined. The main exposure was serum [Na+] variation. Outcome measures were hospital and 1-year all-cause mortalities. RESULTS: A total of 60944 patients, mean age 63 ± 17 years, were studied. On admission, 17% (n = 10066) and 1.4% (n = 852) had hypo- and hypernatremia, respectively. During the hospital stay, 11044 and 4128 developed hypo- and hypernatremia, respectively, accounting for 52.3 and 82.9% of the total hypo- and hypernatremic patients. Serum [Na+] variations of ≥6 mEq/L occurred in 40.6% (n = 24 740) of the 60 944 patients and were significantly associated with hospital and 1-year mortalities after adjusting potential confounders (including demographics, comorbidities, estimated glomerular filtration rate, admission serum [Na+], number of [Na+] measurements and length of hospital stay). Adjusted odds ratios for hospital and 1-year mortalities increased with increasing [Na+] variations in a dose-dependent manner, from 1.47 to 5.48 (all 95% confidence intervals >1.0). Moreover, in fully adjusted models, [Na+] variations (≥6 mEq/L) within the reference range (135-145 mEq/L) or borderline hypo- or hypernatremia (133-137 and 143-147 mEq/L, respectively) compared with 138-142 mEq/L were associated with increased hospital and 1-year mortalities. CONCLUSION: In hospitalized adults, [Na+] fluctuation (≥6 mEq/L) irrespective of admission [Na+] and borderline hypo- or hypernatremia are independent predictors of progressively increasing short- and long-term mortality burdens.
引用
- Thongprayoon C, Cheungpasitporn W, Yap JQ, et al. Increased mortality risk associated with serum sodium variations and borderline hypo- and hypernatremia in hospitalized adults. Nephrol Dial Transplant. 2020. PMID: 31219584. doi:10.1093/ndt/gfz098
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。